State Street’s Biomerica BMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,654
Closed -$21.1K 4267
2025
Q1
$21.1K Hold
4,654
﹤0.01% 4201
2024
Q4
$11.2K Hold
4,654
﹤0.01% 4272
2024
Q3
$12.2K Hold
4,654
﹤0.01% 4255
2024
Q2
$16.4K Hold
4,654
﹤0.01% 4292
2024
Q1
$31K Hold
4,654
﹤0.01% 4241
2023
Q4
$46.5K Hold
4,654
﹤0.01% 4211
2023
Q3
$31.9K Hold
4,654
﹤0.01% 4370
2023
Q2
$50.6K Hold
4,654
﹤0.01% 4412
2023
Q1
$69.6K Hold
4,654
﹤0.01% 4419
2022
Q4
$125K Hold
4,654
﹤0.01% 4299
2022
Q3
$146K Sell
4,654
-2,325
-33% -$60.2K ﹤0.01% 4276
2022
Q2
$161K Hold
6,979
﹤0.01% 4304
2022
Q1
$250K Buy
6,979
+150
+2% +$4.99K ﹤0.01% 4306
2021
Q4
$213K Hold
6,829
﹤0.01% 4321
2021
Q3
$246K Buy
6,829
+50
+0.7% +$1.64K ﹤0.01% 4283
2021
Q2
$217K Buy
+6,779
New +$230K ﹤0.01% 4187

Other funds holding BMRA

State Street's BMRA Position: Q2 2025 in Review

State Street sold out of Biomerica (BMRA) in Q2 2025, closing a stake of 4,654 shares — an estimated $21.1K sold.

State Street first reported a position in BMRA in Q2 2021 and held it in 16 quarters. The position peaked at $250K in Q1 2022. 12 funds tracked by Wall St. Rank hold BMRA as of Q2 2025.

  • State Street reported no remaining Biomerica position as of Q2 2025 after selling out during the quarter.
  • State Street sold 4,654 Biomerica shares in Q2 2025, an estimated $21.1K.
  • State Street first reported a position in Biomerica in Q2 2021 and held it in 16 quarters.
  • State Street's Biomerica position peaked at $250K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Biomerica as of Q2 2025.

Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.